DrugCite
Search

LOXOPROFEN SODIUM

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Loxoprofen Sodium Adverse Events Reported to the FDA Over Time

How are Loxoprofen Sodium adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Loxoprofen Sodium, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Loxoprofen Sodium is flagged as the suspect drug causing the adverse event.

Most Common Loxoprofen Sodium Adverse Events Reported to the FDA

What are the most common Loxoprofen Sodium adverse events reported to the FDA?

Pyrexia
63 (2.19%)
Hepatic Function Abnormal
62 (2.15%)
Renal Failure Acute
54 (1.88%)
Aspartate Aminotransferase Increase...
40 (1.39%)
Alanine Aminotransferase Increased
39 (1.35%)
Renal Impairment
33 (1.15%)
Interstitial Lung Disease
32 (1.11%)
Liver Disorder
32 (1.11%)
Platelet Count Decreased
32 (1.11%)
Diarrhoea
31 (1.08%)
Malaise
30 (1.04%)
Show More Show More
Decreased Appetite
27 (.94%)
Haemoglobin Decreased
27 (.94%)
Anaemia
26 (.9%)
Blood Alkaline Phosphatase Increase...
25 (.87%)
Blood Creatinine Increased
25 (.87%)
Stevens-johnson Syndrome
23 (.8%)
Blood Pressure Decreased
22 (.76%)
Haematocrit Decreased
22 (.76%)
Drug Eruption
21 (.73%)
Dyspnoea
20 (.69%)
Rash
19 (.66%)
Gastric Ulcer Haemorrhage
18 (.63%)
Jaundice
18 (.63%)
Melaena
18 (.63%)
Vomiting
18 (.63%)
Dehydration
17 (.59%)
Disseminated Intravascular Coagulat...
17 (.59%)
White Blood Cell Count Increased
17 (.59%)
Anorexia
16 (.56%)
Urticaria
16 (.56%)
Depressed Level Of Consciousness
15 (.52%)
General Physical Health Deteriorati...
15 (.52%)
Hepatitis Fulminant
15 (.52%)
Red Blood Cell Count Decreased
15 (.52%)
Rhabdomyolysis
15 (.52%)
Gamma-glutamyltransferase Increased
14 (.49%)
Generalised Oedema
14 (.49%)
Large Intestinal Ulcer
14 (.49%)
Pleural Effusion
14 (.49%)
Pneumonia
14 (.49%)
Abdominal Pain Upper
13 (.45%)
Blister
13 (.45%)
C-reactive Protein Increased
13 (.45%)
Infection
13 (.45%)
Lymphocyte Stimulation Test Positiv...
13 (.45%)
Nausea
13 (.45%)
Pruritus
13 (.45%)
Condition Aggravated
12 (.42%)
Pain
12 (.42%)
Renal Tubular Necrosis
12 (.42%)
Shock Haemorrhagic
12 (.42%)
Alopecia
11 (.38%)
Back Pain
11 (.38%)
Blood Bilirubin Increased
11 (.38%)
Blood Lactate Dehydrogenase Increas...
11 (.38%)
Erythema
11 (.38%)
Gastric Ulcer
11 (.38%)
Multi-organ Failure
11 (.38%)
Oliguria
11 (.38%)
Urine Output Decreased
11 (.38%)
Abdominal Pain
10 (.35%)
Blood Glucose Increased
10 (.35%)
Blood Urea Increased
10 (.35%)
Dialysis
10 (.35%)
Fatigue
10 (.35%)
Gait Disturbance
10 (.35%)
Headache
10 (.35%)
Hypokalaemia
10 (.35%)
Loss Of Consciousness
10 (.35%)
Nephropathy
10 (.35%)
Oedema Peripheral
10 (.35%)
Productive Cough
10 (.35%)
Biopsy Kidney Abnormal
9 (.31%)
Cyanosis
9 (.31%)
Diabetes Mellitus Inadequate Contro...
9 (.31%)
Drug Hypersensitivity
9 (.31%)
Dry Mouth
9 (.31%)
Gastrointestinal Haemorrhage
9 (.31%)
Hypoaesthesia
9 (.31%)
Inflammation
9 (.31%)
Peritonitis
9 (.31%)
Renal Failure
9 (.31%)
Urinary Casts Present
9 (.31%)
Acquired Haemophilia
8 (.28%)
Colitis Collagenous
8 (.28%)
Drug Interaction
8 (.28%)
Haemodialysis
8 (.28%)
Hepatitis Acute
8 (.28%)
Hypertension
8 (.28%)
Hypovolaemic Shock
8 (.28%)
Insomnia
8 (.28%)
Metabolic Acidosis
8 (.28%)
Rheumatoid Arthritis
8 (.28%)
Sepsis
8 (.28%)
Swelling
8 (.28%)
Toxic Epidermal Necrolysis
8 (.28%)
Cerebral Infarction
7 (.24%)
Chills
7 (.24%)
Diabetes Mellitus
7 (.24%)
Drug Ineffective
7 (.24%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Loxoprofen Sodium, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Loxoprofen Sodium is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Loxoprofen Sodium

What are the most common Loxoprofen Sodium adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Loxoprofen Sodium, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Loxoprofen Sodium is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Loxoprofen Sodium According to Those Reporting Adverse Events

Why are people taking Loxoprofen Sodium, according to those reporting adverse events to the FDA?

Rheumatoid Arthritis
423
Pain
129
Product Used For Unknown Indication
91
Drug Use For Unknown Indication
85
Pyrexia
80
Back Pain
74
Show More Show More
Cancer Pain
65
Headache
39
Upper Respiratory Tract Inflammatio...
34
Premedication
19
Prophylaxis
19
Sciatica
19
Herpes Zoster
18
Nasopharyngitis
18
Ill-defined Disorder
17
Pain In Extremity
15
Analgesic Therapy
15
Osteoarthritis
14
Arthralgia
14
Crohns Disease
13
Pharyngitis
11
Fabrys Disease
11
Osteoporosis
11
Post Herpetic Neuralgia
10
Oropharyngeal Pain
8
Procedural Pain
7
Postoperative Care
6
Musculoskeletal Pain
6
Compression Fracture
6
Spinal Cord Injury Thoracic
6
Abdominal Pain
6
Antipyresis
5
Neuralgia
5
Wound Complication
5
Pain Management
5
Bone Pain
5
Oedema Peripheral
5
Bronchitis
5
Inflammation
4
Analgesic Effect
4
Spondylitis
4
Neck Pain
4
Cough
3
Upper Respiratory Tract Infection
3
Infection Prophylaxis
3
Pleurisy
3
Spinal Column Stenosis
3
Oral Pain
3
Wound Abscess
3
Juvenile Arthritis
3
Dental Caries
3

Loxoprofen Sodium Case Reports

What Loxoprofen Sodium safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Loxoprofen Sodium. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Loxoprofen Sodium.